Summary: | Made available in DSpace on 2014-06-11T19:28:03Z (GMT). No. of bitstreams: 0
Previous issue date: 2009-03-30Bitstream added on 2014-06-13T20:17:46Z : No. of bitstreams: 1
passoni_mh_me_arafcf.pdf: 404173 bytes, checksum: 0602419a359e80c6739ffbcafd458c33 (MD5) === Universidade Estadual Paulista (UNESP) === A teicoplanina é um antibiótico glicopeptídico, cujo mecanismo de ação é inibir a síntese da parede celular bacteriana. Esse antibiótico vem sendo bastante utilizado no Brasil no combate a bactérias Gram-positivas multiresistente a fármacos. Em razão deste fármaco ser relativamente novo no mercado, não há metodologia de análise descrita em compêndios oficias. Este trabalho apresenta procedimentos para quantificação de teicoplanina em pó para solução injetável. O método espectrofotometrico na região ultravioleta a 279 nm, na faixa de concentração de 60,0 a 110,0 μg/mL (r2 = 0,999), apresentou linearidade, precisão e exatidão, com teor médio no pó para solução injetável de 97,45%. A cromatografia líquida de alta eficiência utilizou coluna C18 (4,6 x 250 mm, 5 mm) e a fase móvel constituída de metanol : acetonitrila (50:50, V/V), na faixa de concentração de 70,0 a 120,0 mg/mL (r2 = 0,999) e apresentou linearidade, precisão e exatidão, com teor médio no pó para solução injetável de 99,12%. Os dados foram calculados pela análise de variância (ANOVA), permitindo assim aplicação destes métodos no controle de qualidade. === Teicoplanin is a glycopeptide antibiotic, which inhibits the bacteria cellular membrane synthesis. This antibiotic is quite new and has been used in Brazil to combat Gram-positive bacteria that are multi-drug resistant. There is not described analytical methodology in official literature. This work reports procedures for the quantification of teicoplanin in pharmaceutical forms. In the UV-spectrophotometry at 279 nm, the Lambert-Beer law was obeyed in the concentration range from 60.0 to 110.0 μg/mL (r2 = 0,999), whose analysis presented linearity, precision and accuracy, with average in powder for injection of 97.45. In the second method, HPLC methods, the samples were injected into a Waters Symmetry C18 column (4.6 x 250 mm, 5 mm). The mobile phase was consisted of acetonitrile and methanol (50:50, V/V). UV detection was performed at 279 nm, and the samples and reference solutions were prepared in the mobile phase; the calibration curve for teicoplanin was linear from 70.0 to the 120.0 mg/mL range (r2 = 0.999). The procedure presented linearity, precision, accuracy, with average in powder for injection of 99.12%. The statistical data were calculated by analysis of variance (ANOVA), that it allows the application of the analytical methods in the quality control of pharmaceutical preparations.
|